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Abstract
Background: Anti-N-methyl-D-aspartate receptor encephalitis is an increasingly common autoimmune disorder
mediated by antibodies to certain subunit of the N-methyl-D-aspartate receptor. Recent literatures have described
anti-thyroid and infectious serology in this encephalitis but without follow-up.
Case presentation: A 17-year-old Chinese female patient presented with psychiatric symptoms, memory deficits,
behavioral problems and seizures. She then progressed through unresponsiveness, dyskinesias, autonomic
instability and central hypoventilation during treatment. Her conventional blood work on admission showed high
titers of IgG antibodies to thyroglobulin, thyroid peroxidase and IgM antibodies to Epstein-Barr virus viral capsid
antigen. An immature ovarian teratoma was found and removal of the tumor resulted in a full recovery. The final
diagnosis of anti-N-methyl-D-aspartate receptor encephalitis was made by the identification of anti-N-methyl-D-
aspartate receptor antibodies in her cerebral spinal fluid. Pathology studies of the teratoma revealed N-methyl-D-
aspartate receptor subunit 1 positive ectopic immature nervous tissue and Epstein-Barr virus latent infection. She
was discharged with symptoms free, but titers of anti-thyroid peroxidase and anti-thyroglobulin antibodies
remained elevated. One year after discharge, her serum remained positive for anti-thyroid peroxidase and anti-N-
methyl-D-aspartate receptor antibodies, but negative for anti-thyroglobulin antibodies and IgM against Epstein-Barr
virus viral capsid antigen.
Conclusions: Persistent high titers of anti-thyroid peroxidase antibodies from admission to discharge and until one
year later in this patient may suggest a propensity to autoimmunity in anti- N-methyl-D-aspartate receptor
encephalitis and support the idea that neuronal and thyroid autoimmunities represent a pathogenic spectrum.
Enduring anti-N-methyl-D-aspartate receptor antibodies from admission to one year follow-up but seroreversion of
Epstein-Barr virus viral capsid antigen IgM may raise the important issue of elucidating the triggers and boosters of
anti- N-methyl-D-aspartate receptor encephalitis.
Background
Anti-N-methyl-D-aspartate receptor encephalitis (anti-
NMDAR encephalitis) is a newly identified autoimmune
encephalitis associated with antibodies against functional
NMDA receptors that predominantly affects young
females and exhibits a well defined set of clinical
features [1]. Unlike classic paraneoplastic limbic ence-
phalpathies with onconeural antibodies directed to intra-
cellular antigens, anti-NMDAR encephalitis harbors
antibodies against neuronal extracellular membrane N-
methyl-D-aspartate receptor subunit 1 (NR1) of NMDA
receptor, and may not be accompanied with tumors [2].
It has been demonstrated that anti-NR1 antibodies
selectively bind, cross-link, and internalize surface
NMDA receptors, and lead to decreased postsynaptic
NMDA receptor-mediated currents in a reversible and
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studies showed few patients with non-tumor-associated
anti-NMDAR encephalitis have evidence of elevated
anti-thyroid peroxidase (anti-TPO) antibodies [4-7],
there is lack of anti-NMDAR and anti-TPO antibodies
combined follow-up in details in current literatures. The
majority of patients with anti-NMDAR encephalitis have
a prodromal flu-like illness. In line with this, numerous
pathogens have been implicated and identified on serum
studies, including mycoplasma pneumoniae [4,5], influ-
enza virus A, influenza virus B, Chlamydia pneumoniae,
Bordetella pertussis and parapertussis [7]. To our
knowledge, this represents the first anti-NMDAR ence-
phalitis case associated with serum Epstein-Barr virus
viral capsid antigen IgM (EBV-VCA-IgM).
Case presentation
An otherwise healthy 17-year-old urban high school girl
was brought to the emergency room for episodes of
generalized tonic-clonic convulsions of all extremities.
She was described to have auditory hallucination by
complaining about the “noisy” electric wire in her bed-
room three days ago. She had no history of tobacco,
alcohol, or drug use. The family history and previous ill-
nesses of the patient were unrevealing. Upon arrival, her
axillary temperature was 37.6°C. She was not oriented to
person, place or time. She couldn’t recall what teachers
had taught few hours ago and had difficulty in perform-
ing serial 7’s. Standard blood screening tests revealed
increased white blood cell count (15.66 × 10
9/L, normal
range 4~10 × 10
9/L) but normal lymphocyte count (1.44
×1 0
9/L, normal range 0.8~4 × 10
9/L). Cerebrospinal
fluid (CSF) analyses were unremarkable, including anti-
bodies panel of anti-thyroglobulin (TG) antibodies (4.6
U/ml, normal range 0~60 U/ml, radioimmunoassay),
anti-TPO antibodies (18.1 U/ml, normal range 0~60 U/
ml, radioimmunoassay) and negative EBV-VCA-IgM
(enzyme-linked immunosorbent assay, ELISA). Blood
and urine screenings for drug abuse and toxication were
negative. She was admitted to the neurology ward; acy-
clovir (1500 mg IV QD) was started for empiric treat-
ment of viral encephalitis.
After further investigation, her EBV-VCA-IgM, EBV-
VCA-IgG and EBV nuclear antigen IgG (EBNA-IgG)
seropositivities were identified with ELISA. Serum
tumor markers, antinuclear antibodies, anti-extractable
nuclear antigen antibodies and anti-Hu, Yo, Ri antibo-
dies were all negative or within normal limits. Mag-
netic resonance imaging (MRI) of brain was normal.
Electroencephalography (EEG) on day 2 demonstrated
abnormal diffuse low-voltage fast-activities (Figure 1A),
when patient was alert but with psychiatric symptoms,
saying"How can I become taller? My father is short of
money ! I’m going to die !” Radioimmunoassay showed
markedly elevated anti-TG (138 U/ml, normal range
0~60 U/ml) and anti-TPO (> 1300 U/ml, normal range
0~60 U/ml) antibodies in her serum, yet her serum
T3, FT3, T4, FT4, TSH levels along with thyroid ultra-
sonography were normal. Over the next few days, the
patient’s consciousness level gradually decreased. She
then developed occasional lip licking and tongue pro-
trusion with convulsions of all extremities. Valproic
acid and oxcarbazepine were used successively and
then simultaneously, however, her oral-facial dyskine-
sias and extremities convulsions persisted despite the
use of dual anticonvulsant therapy. Repeat lumbar
puncture on day 6 revealed elevated CSF opening pres-
sure (21 cm H2O, normal range 8~18 cm H2O), pro-
tein concentration (58.0 mg/dl, normal range 20~40
mg/dl) and pleocytosis (73 × 10
6/L, normal range 0~10
×1 0
6/L) as well.
Routine abdominal and pelvic ultrasound on day 5
revealed a cyst in the left adnexa, which was 10 cm in
diameter. The pelvic computed tomography scan with
enhancement next day showed a calcified hypodense
c y s t i cl e s i o n( 1 0 . 5c m×6 . 2c m×6 . 0c m )a n da no v a r -
ian teratoma was suspected (Figure 2A). From day 7 on,
the patient received intravenous immunoglobulin (0.4 g/
kg body weight/day, 5 days), followed by intravenous
methylprednisolone (500 mg/day, 3 days). Another EEG
o nd a y1 1d e m o n s t r a t e da na b e r r a n tu n i v e r s a ld e l t a
activity (Figure 1B) when the patient was in coma. On
day 17, the patient presented hypersalivation and sinus
tachycardia (ranging from 100~130 beats/min) without
hyperthermia and convulsions. On day 19, her arterial
blood gas analysis suggested CO2 retention. She was
intubated and mechanically ventilated. On day 21, she
could follow simple commands such as blinking eyes
and grasping fists. From day 22 on, her consciousness
started to recover with less frequent paroxysmal events
(ie. oral-facial dyskinesias and extremities convulsions)
happened. A left salpingooophorectomy was performed
on day 26 and the mass was completely removed. The
pelvic lymph nodes and peritoneal washings were nega-
tive. Final pathology diagnosis was immature cystic tera-
toma of the left ovary, stage I, and grade 1.
One day following resection of the teratoma, the
patient was successfully weaned from the ventilator. Par-
oxysmal events had also been controlled with valproic
acid and oxcarbazepine. On day 32 (the 6
th day after
operation), her consciousness was fully recovered, short-
term memory, orientation and calculation examinations
were also normal. On day 34 (the 8
th day after opera-
tion), patient’s EEG demonstrated the return of back-
ground alpha rhythm with few theta activity (Figure 1C)
and she could speak fluently without lip licking and
chewing. At the same time, antibodies to NR1 were
identified in patient’s CSF.
Xu et al. BMC Neurology 2011, 11:149
http://www.biomedcentral.com/1471-2377/11/149
Page 2 of 7Fifty-seven days following onset of symptoms and 54
days following admission, the patient was discharged,
symptom free. Repeat MRI and EEG were normal (Fig-
ure 1D). Serum anti-TG antibodies (361 U/ml, normal
range 0~60 U/ml) and anti-TPO antibodies (> 1300 U/
ml, normal range 0~60 U/ml) remained elevated.
Pathological findings of immature ovarian teratoma
Both NR1 positive primitive neural tubes (Figure 2B)
and neurofilament positive ganglion cells were found in
the teratoma (Figure 2C).
In situ hybridization (ISH) for detecting latent EBV
infection in teratoma was performed with the Epstein-
Barr virus encoded RNA (EBER)-probe ISH kit (Triplex,
Fuzhou, China) according to the manufacturer’s instruc-
tions. Dark brown nuclear staining identified a positive
hybridization. In current case, EBER ISH revealed scat-
tered latent EBV infected cells in mucinous glandular
epithelium of the teratoma (Figure 2D), an EBV infected
NK/T cell lymphoma (Figure 2E) served as positive
control.
One year follow-up of patient’s antibodies in serum
During one year follow-up of the patient, her physical
examinations and EEG were unremarkable. Her serum
was sent for conventional tests for anti-TPO, anti-TG
antibodies with radioimmunoassay and EBV-VCA-IgM
with ELISA. Meanwhile, patient’s serum IgG antibodies
against TPO, TG, NMDAR, EBV-VCA, EBV early anti-
gen (EBV-EA), EBNA, IgG avidity of EBV-VCA and
IgM antibodies against EBV-VCA were also detected by
indirect immunofluorescence assays according to the
manufacturer’s recommendations (Euroimmune AG,
Lübeck, Germany). Another Hashimoto thyroiditis
patient’s serum with high titers of both anti-TPO and
anti-TG antibodies confirmed by radioimmunoassay was
employed as positive control in indirect immunofluores-
cence assay.
Figure 1 Serial electroencephalographies of the patient without sedation. (A) Recording on day 2 showed background rhythm was taken
place by abnormal diffuse low-voltage fast-activities, when patient was alert but with psychiatric symptoms. (B) Recording on day 11 revealed
aberrant universal delta activity, when patient was in coma. (C) Recording on day 34 (8
th day after teratoma removal) demonstrated the return of
background alpha rhythm with few theta activity, when the patient’s conscious was recovered without oral-facial dyskinesias or extremities
convulsions. (D) Recording on day 44 (18
th day after teratoma removal) showed a normal alpha activity. The calibration marks represent 1
second and 100 μV.
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(51.8 U/ml, normal range 0~60 U/ml). Anti-TPO anti-
body level remained elevated (> 1300 U/ml, normal
range 0~60 U/ml). Serum EBV-VCA-IgM was negative
by ELISA.
In indirect immunofluorescence assays, the patient’s
serum autoantibodies against TPO made a granular
staining in the cytoplasm of t h ef o l l i c l ee p i t h e l i u m
(Figure 3A, white arrowheads). Serum of a Hashimoto
thyroiditis patient served as positive control, showing
both granular staining in the cytoplasm of the follicle
epithelium (Figure 3B, white arrowheads) and coarse
staining in the colloid of follicles (Figure 3B, white aster-
isk), which represented anti-TPO and anti-TG seroposi-
tivity, respectively. Phosphate buffered saline (PBS)
solution added as negative control gave neither of the
Figure 2 Computed tomography of the pelvis (A) revealed a cystic left adnexal mass with an internal focus of fat and high
attenuation material suggesting an ovarian teratoma (asterisk). N-methyl-D-aspartate receptor subunit 1 (NR1) immunostain demonstrated
primitive neural tubes (B) within teratoma, while neurofilament immunostain showed mature ganglion cells (C). Epstein-Barr virus encoded RNA
(EBER) in situ hybridization revealed scattered latent EBV infected cells in mucinous glandular epithelium of the teratoma (D, brown color), an
EBV infected NK/T cell lymphoma (E) served as positive control. (For panels B to E, bars = 50 μm).
Figure 3 Indirect immunofluorescene assays with patient’s serum obtained one year after symptoms onset (dilution 1:10) revealed
anti-TPO antibodies specific granular staining in the cytoplasm of the follicle epithelium (A, white arrowheads). Serum of another
Hashimoto thyroiditis patient served as positive control showed both granular staining in the cytoplasm of the follicle epithelium (B, white
arrowheads) and coarse staining in the colloid of follicles (B, white asterisk), which represented anti-TPO and anti-TG seropositivity, respectively.
Phosphate buffered saline solution added as negative control gave neither of the above mentioned fluorescence pattern (C). Positive staining
was observed after human embryonic kidney cells transfected with NMDA receptors was incubated with patient’s serum (dilution 1:10),
confirming the continuing presence of autoantibodies against NMDA receptors (D), while patient’s serum didn’t react with untransfected human
embryonic kidney cells (E). As for the EBV associated serostatus, EBV-VCA-IgG (F), high avidity EBV-VCA-IgG (G) and EBNA-IgG (J) were present in
patient’s serum, while EBV-VCA-IgM (H) and EBV-EA-IgG (I) were absent, suggesting a chronic EBV infection without relapse or reactivation during
follow-up. (Magnifications: 10 × F~J, 20 × A~C and 40 × D~E).
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tive staining was observed after human embryonic kid-
ney cells transfected with NMDA receptors was
incubated with patient’s serum, confirming the continu-
ing presence of autoantibodies against NMDA receptors
(Figure 3D), while patient’s serum didn’t react with
untransfected human embryonic kidney cells (Figure
3E). As for the EBV associated serostatus, EBV-VCA-
IgG (Figure 3F), high avidity EBV-VCA-IgG (Figure 3G)
a n dE B N A - I g G( F i g u r e3 J )w e r ep r e s e n ti np a t i e n t ’s
serum, while EBV-VCA-IgM (Figure 3H) and EBV-EA-
IgG (Figure 3I) were absent, suggesting a chronic EBV
infection without relapse or reactivation.
Discussions
Our case followed a classic clinical picture of anti-
NMDAR encephalitis resulting from the loss of NR1
subunit of NMDA receptors as presented in the current
literatures, including psychotic behavior, disruption of
dopaminergic pathway (orofacial movement), dysautono-
mia (cardiac dysrhythmia, hypersalivation, central hypo-
ventilation) and memory deficits are similar to those
obtained with models of genetic or pharmacologic
attenuation of NMDA receptors function [8-10]. High
titers of serum anti-TPO antibodies suggested comorbid
diagnosis of Hashimoto encephalopathy (HE) requires
further attentions. The presence of serum EBV-VCA-
IgM (not previously described in patients with anti-
NMDAR encephalitis) provides further evidence that
anti-NMDAR encephalitis is not merely a paraneoplastic
disorder, but that a probable postinfectious autoimmue
process contributes to disease presentation.
HE is a steroid-responsive encephalopathy associated
with elevated blood concentrations of anti-thyroid anti-
bodies and euthyroid or mildly hypothyroid function.
Alink summarized 25 pediatric HE cases mainly with
acute manifestations, among which the most frequent
symptoms were seizures (80%), confusion (52%), halluci-
nations (32%), and only halfo ft h ep a t i e n t sd e v e l o p
abnormal neuroimaging [11]. The diagnosis of HE
requires both detection of high concentrations of anti-
TPO antibodies in serum, and exclusion of other toxic-
metabolic encephalopathies. From above mentioned
aspects, the current case met the diagnostic criteria for
HE [12] until both the ovary immature teratoma and
anti-NMDAR antibodies were identified. In the present
case, serum anti-TPO antibodies remained elevated one
year after discharge, despite resolution of clinical symp-
toms, further suggesting that the likely diagnosis in this
case was anti-NMDAR encephalitis. Although, anti-TPO
antibodies directed at microsomes and released from
damaged thyroid cells were found in all HE cases, they
have also been found in autoimmmue diseases ranging
from type 1 diabetes mellitus to rheumatoid arthritis
[13,14], even in euthyroid individuals [15]. Hence, clini-
cians should be cautioned against accepting HE as the
sole explanation for an encephalitic illness, after exclud-
ing conventional metabolic, infectious or vascular etiolo-
gies, and merely based on anti-TPO test. On the other
hand, with evolving case studies of anti-NMDAR ence-
phalitis, more and more authors regard HE as an impor-
tant differential diagnosis [16-20]. Recently, Tüzün and
colleagues compared serum autoantibodies to neuronal
surface antigens in serum thyroid antibody-positive and
-negative limbic encephalitis, suggesting patients with
anti-thyroid antibodies are inclined to develop anti-neu-
ronal immune responses and autoimmune encephalitis
such as anti-NMDAR encephalitis, which supported the
notion that neuronal and thyroid autoimmunities might
represent a pathogenic spectrum [21]. Interestingly,
although prednisone is known to reduce thyroid antibo-
dies titers, several courses of immunotherapy had no
effect on sera anti-TPO antibodies reduction in current
case. Her serum anti-TPO antibodies were still elevated
when she was discharged and had persisted for a year
after dismissal, which suggested a propensity for autoim-
munity in anti-NMDAR encephalitis.
A high incidence of prodromal hyperthermia and
viral-like symptoms during the course of anti-NMDAR
encephalitis frequently lead to extensive studies to rule
out infections [2,22]. Although some positive infectious
serology has been reported in anti-NMDAR encephalitis
cases, not a common pathogen has been identified even
in cases without tumors [23]. The preceding active EBV
infection or reactivation suggested by EBV-VCA-IgM in
this case hasn’t been previously reported.
In developing countries like China, primary EBV infec-
tion is usually asymptomatic and occurs through close
contacts between parents and children within the first 3
years of life [24]. Therefore, given lack of typical EBV
infection symptoms and blood lymphoctosis, EBV-VCA-
IgM seropositivity of current adolescent case on admis-
sion was not due to primary EBV infection but probably
recent EBV reactivation. In addition, evidence of acute
hepatitis A virus or HIV infections, which had been
reported to have false positive reactions of the EBV-
VCA-IgM ELISA was absent in this patient [25]. Follow-
up EBV-VCA-IgM seroreversion proved by both ELISA
and indirect immunofluorescence assay which is known
as gold standard for highly sensitive and monospecific
antibody detection [26], further excluded the persisting
EBV-VCA-IgM seropostive status and reinforced the
credibility of our conventional ELISA methodology. It is
well acknowledged that the titer of CSF anti-NMDAR
antibodies appears to correlate more closely with the
clinical outcome than serum antibodies and prolonged
follow-up studies have found anti-NMDAR antibodies in
CSF and serum [2,3,27,28]. Depriving NR1 as
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antibody titers by previous immunotherapies may
explain the prolonged symptom-free intervals in those
cases. Taking into account different EBV-VCA-IgM ser-
ostatus from admission to one year follow-up, we pro-
posed the prodromal EBV reactivation and following
cascade may also contribute to triggering and boosting
the immune response or facilitate autoantibodies cross-
ing the blood-brain barrier in our patient one year ago
[23]. Controlled studies are expected to compare the
concomitant infectious or inflammatory status of
patients with and without prodromal flu-like symptoms
and may shed new light on the pathophysiology of anti-
NMDAR encephalitis.
In chronic aspects, persistence and reactivation of EBV
is presumed to elicit autoimmunity in multiple sclerosis,
systemic lupus erythematosus, rheumatoid arthritis,
myasthenia gravis, Hashimoto thyroiditis, etc [24,29,30],
but hasn’t been linked with anti-NMDAR encephalitis
up to now. Following primary infection, EBV latency is
maintained by expression of a set of viral proteins that
deliver activation, growth, and survival signals to
infected B cells. These B cells are able to cross the
blood-brain barrier, and are believed to undergo resti-
mulation, antigen-driven affinity maturation, clonal
expansion, and differentiation into antibody-secreting
plasma cells which may cause damage in self-tissues
[31]. EBV has also been associated with numerous can-
cers such as Burkitt’s lymphoma, Hodgkin lymphoma,
nasopharyngeal carcinoma, gastric adenocarcinoma and
even breast cancer [24], the latent EBV infection in this
immature teratoma proved by EBER ISH may either
suggest oncogenicity of EBV in teratoma or underlying
EBV related immunopathogenesis of anti-NMDAR ence-
phalitis as we proposed previously.
The improvement in the clinical presentation with
therapies also can be correlated to the resolution of the
EEG changes (Figure 1A-D). Although the patient was
lack of severe stressors and functioned very well in daily
life before falling ill, she presented clinical spectrum of
seizures, agitation, autonomic instability and hypoventi-
lation compatible with a catatonic disorder [32,33].
Nevertheless, without aggressive management of the
observable symptoms of catatonia, the most profound
improvements in psychiatric and behavioral symptoms
occurred after the teratoma had been resected. Unlike
recently reported two non-tumor associated anti-
NMDAR encephalitis cases with anti-TPO and infec-
tious serology concurrence [7], the patient had complete
clinical recovery both on discharge and one year later,
which may also due to timely tumor resection. However,
controlled studies and more cases are still necessary to
prove the real effectiveness of IV immunoglobulin and
IV steroids recommended as first line immunotherapies
by some authors [19,26] in anti-NMDAR encephalitis.
Factors related to the surgery including anesthetics or
induction of sleep may not be account for patient’sc l i n -
ical improvements, for propofol and midazolam admi-
nistered during endotracheal intubation hadn’tc h a n g e
the course of her illness.
Limitations
Due to the limited amount of teratoma tissue available,
we could not further characterize whether tumoral cells
or infiltrating lymphocytes were positively EBER hybri-
dized. Thus, from the data provided we couldn’td i s t i n -
guish local (specific and neoplastic) versus systemic
(nonspecific and lymphocytic) EBV latent infection in
the teratoma. On follow-up assessment, our patient
refused repeat lumbar puncture limited our ability to
comment on CSF anti-NMDAR antibody titer.
Conclusions
In summary, persistent high titers of serum anti-thyroid
peroxidase antibodies from admission to discharge and
until one year later in our patient may not only suggest
a propensity to autoimmunity in anti-NMDAR encepha-
litis, but support the notion that neuronal and thyroid
autoimmunities represent a pathogenic spectrum. The
enduring anti-NMDAR antibodies positivity from admis-
sion to one year follow-up, EBV latent infected ovarian
teratoma, and seroreversion of EBV-VCA-IgM of cur-
rent case might also raise the issue of elucidating the
triggers and boosters of this autoimmune encephalopa-
thy in the future.
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